XML 20 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:      
Cash received from customers and grants $ 24,971,299 $ 16,947,194 $ 30,174,083
Cash paid to suppliers and employees (30,028,299) (23,677,476) (28,382,681)
Interest received 22,485 25,548 2,412
Interest paid 0 0 (836)
Net cash (used in) provided by operating activities (5,034,515) (6,704,734) 1,792,978
CASH FLOWS FROM INVESTING ACTIVITIES:      
Acquisition of license 0 0 (550,000)
Purchase of RVR Diagnostics Sdn Bhd (850,000) (550,000) 0
Acquisition of and deposits on fixed assets (1,026,954) (118,706) (480,585)
Net cash used in investing activities (1,876,954) (668,706) (1,030,585)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from option and warrant exercises 34,800 57,575 0
Proceeds from note payable 99,480 0 0
Proceeds from credit line 0 0 700,000
Repayment of credit line 0 0 (700,000)
Proceeds from sale of common stock, net 0 12,493,398 0
Net cash provided by financing activities 134,280 12,550,973 0
Effect of exchange rate changes on cash 13,027 0 0
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (6,764,162) 5,177,533 762,393
Cash and cash equivalents - beginning of the period 10,554,464 5,376,931 4,614,538
Cash and cash equivalents - end of the period 3,790,302 10,554,464 5,376,931
RECONCILIATION OF NET LOSS TO NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES:      
Net Loss (6,371,760) (13,347,047) (2,397,042)
Adjustments:      
Depreciation and amortization 1,276,963 1,139,228 1,372,563
Provision for (benefit from) deferred taxes 0 5,800,818 (1,170,969)
Fair value adjustment to contingent consideration (148,000) 0 0
Share based compensation 384,897 304,154 334,386
Changes in assets and liabilities:      
Accounts receivable 1,298,389 (960,758) 5,915,918
Inventories (1,088,430) 242,837 60,274
Prepaid expenses and other current assets 285,762 (136,258) (190,960)
Deposits and other assets (512,272) 1,480 0
Accounts payable and accrued liabilities 182,453 211,701 (2,144,598)
Deferred revenue (342,517) 39,111 13,406
Net cash (used in) provided by operating activities (5,034,515) (6,704,734) 1,792,978
Supplemental disclosures for non-cash investing and financing activities:      
Deposits on manufacturing equipment transferred to fixed assets 174,399 0 20,017
Accrual of contingent earn-out 148,000 0 0
Issuance of common stock for net assets of business acquired $ 1,682,725 $ 0 $ 0